# STAT3 in T Cells: At The Crossroads of Inflammation and Cancer

> **NCT01663571** · — · TERMINATED · sponsor: **NYU Langone Health** · enrollment: 35 (actual)

## Conditions studied

- Cutaneous T Cell Lymphoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01663571
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2012-05-01
- **Primary completion:** 2016-11-21
- **Final completion:** 2016-11-21
- **Target enrollment:** 35 (ACTUAL)
- **Why stopped:** Study is permanently closed to enrollment .Collection of private identifiable information is complete Analysis of private identifiable information is complete
- **Last updated:** 2018-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01663571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01663571, "STAT3 in T Cells: At The Crossroads of Inflammation and Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01663571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*